```html

Aortic Stenosis – Everything You Need to Know

What is Aortic Stenosis?

Aortic stenosis (AS) is a narrowing of the aortic valve opening, the one‑way gate that allows blood to flow from the left ventricle of the heart into the aorta and then to the rest of the body. When the valve becomes stiff, thickened, or fused, it cannot open fully. As a result, the heart must work harder to push blood through the reduced opening, which can eventually lead to heart failure, fainting, or sudden cardiac death if left untreated.

The condition is graded by the size of the valve area (normal ≈ 3–4 cm²):

• Mild: > 1.5 cm²
• Moderate: 1.0‑1.5 cm²
• Severe: < 1.0 cm²

Most people with mild AS have no symptoms and may never need surgery, whereas severe AS often requires definitive treatment (valve replacement or repair) before complications develop.

Common Causes

While aortic stenosis can be congenital (present at birth), the majority of cases in adults are acquired. The following conditions are the most frequent contributors:

• Age‑related calcific degeneration: Calcium deposits build up on the valve leaflets, most common after age 65.
• Bicuspid aortic valve: A congenital abnormality where the valve has two leaflets instead of three; predisposes to earlier calcification.
• Rheumatic fever: An autoimmune reaction after a streptococcal infection that can scar and fuse valve leaflets.
• Radiation therapy: Chest irradiation (e.g., for lymphoma) can cause fibrosis and calcification of the valve.
• Chronic kidney disease (CKD):** Disturbed calcium‑phosphate metabolism accelerates valve calcification.
• Hyperlipidemia and atherosclerosis: Lipid deposits promote inflammation and calcific changes.
• Familial hypercholesterolemia: Genetic high‑cholesterol levels increase early calcific disease.
• Endocarditis: Infection of the valve can scar the leaflets, leading to stenosis.
• Congenital stenosis (other than bicuspid): Rare structural abnormalities present at birth.
• Connective‑tissue disorders (e.g., Marfan, Ehlers‑Danlos): May affect valve integrity and promote early degeneration.

Associated Symptoms

Symptoms typically appear only after the valve area has narrowed enough to limit cardiac output. Common manifestations include:

• Dyspnea (shortness of breath): Often first noticed during exertion or when lying flat (orthopnea).
• Chest pain (angina): Caused by reduced blood flow to the coronary arteries during exertion.
• Syncope (fainting) or near‑syncope: Especially during activity or standing up quickly.
• Fatigue and reduced exercise tolerance: The heart cannot meet the body's oxygen demand.
• Palpitations: Irregular heartbeats may develop as the left ventricle enlarges.
• Heart murmur: A harsh, systolic ejection click heard best at the right upper sternal border; often the first clue found by a clinician.
• Peripheral edema: Swelling of the ankles or feet in advanced disease.

Many patients remain asymptomatic for years, which is why routine cardiac evaluation in at‑risk groups (elderly, bicuspid valve, CKD) is essential.

When to See a Doctor

Prompt medical evaluation is warranted if you notice any of the following:

• New or worsening shortness of breath, especially with activity or when lying down.
• Chest discomfort that occurs during physical exertion.
• Fainting, light‑headedness, or sudden loss of balance.
• Rapid increase in fatigue that limits daily tasks.
• A heart murmur detected during a routine exam.
• Swelling of the ankles, feet, or abdomen.

Even if symptoms are mild, seeing a healthcare professional allows for early imaging and risk stratification.

Diagnosis

Diagnosing aortic stenosis involves a combination of clinical assessment and imaging studies.

1. Physical Examination

• Detection of a systolic ejection murmur with a characteristic “crescendo‑decrescendo” shape.
• Pulse paradoxus or diminished peripheral pulses in severe cases.

2. Echocardiography (Echo)

The gold‑standard test. A transthoracic echo (TTE) measures:

• Valve area and gradient (pressure difference across the valve).
• Left‑ventricular wall thickness and ejection fraction.
• Presence of associated regurgitation or other valve disease.

3. Cardiac Catheterization

Reserved for patients being evaluated for surgery or when non‑invasive studies are inconclusive. It directly measures pressures in the heart chambers.

4. Advanced Imaging (CT or MRI)

• CT calcium scoring quantifies calcific burden.
• MRI can assess ventricular function and myocardial fibrosis.

5. Electrocardiogram (ECG)

May reveal left‑ventricular hypertrophy, atrial fibrillation, or conduction abnormalities that influence management.

6. Blood Tests

• Kidney function, lipid profile, and inflammatory markers (e.g., CRP) help identify reversible contributors.

Treatment Options

Treatment is tailored to symptom severity, valve anatomy, and overall health.

Medical Management (for mild‑to‑moderate disease)

• Blood pressure control: ACE inhibitors, ARBs, or beta‑blockers to reduce afterload.
• Lipid‑lowering therapy: Statins are recommended for atherosclerotic risk, though they do not reverse valve calcification.
• Management of comorbidities: Diabetes, CKD, and arrhythmias should be optimally treated.
• Lifestyle counseling: Regular, low‑impact aerobic activity (e.g., walking) as tolerated.
• Regular monitoring: Echo every 1–2 years for mild disease; every 6–12 months for moderate disease.

Interventional/Surgical Treatment (for severe or symptomatic disease)

• Surgical Aortic Valve Replacement (SAVR): Removal of the diseased valve and implantation of a mechanical or bioprosthetic valve. Preferred in younger, low‑risk patients.
• Transcatheter Aortic Valve Implantation (TAVI/TAVR): A catheter‑based valve placed via the femoral artery or a small chest incision. Recommended for older patients, those with high surgical risk, or those with prior chest radiation.
• Balloon Valvuloplasty: Temporary dilation for patients who cannot undergo surgery or TAVI, usually as a bridge to definitive therapy.

Post‑procedure Care

• Anticoagulation for mechanical valves (warfarin) or antiplatelet therapy for bioprosthetic valves (aspirin).
• Endocarditis prophylaxis before certain dental or invasive procedures (per AHA guidelines).
• Cardiac rehabilitation to improve functional capacity.

Prevention Tips

While you cannot change a congenital bicuspid valve, many risk factors for calcific AS are modifiable:

• Control blood pressure: Keep systolic < 130 mmHg.
• Maintain healthy cholesterol: LDL < 100 mg/dL for most adults; <70 mg/dL if high cardiovascular risk.
• Stop smoking: Smoking accelerates atherosclerosis and valve calcification.
• Manage diabetes: Tight glycemic control reduces vascular calcification.
• Stay active: Aim for at least 150 minutes of moderate‑intensity exercise each week.
• Limit calcium‑phosphate imbalance: In CKD, follow nephrology recommendations for phosphate binders and vitamin D analogs.
• Vaccinate against influenza and pneumococcus: Respiratory infections can exacerbate heart strain.
• Regular check‑ups: Adults over 65 should have a cardiac exam (including murmur auscultation) every 1–2 years.

Emergency Warning Signs

Key Take‑aways

Aortic stenosis is a progressive valve disease that can remain silent for years but may culminate in serious cardiac complications if not identified early. Recognizing risk factors, undergoing routine cardiac screening when appropriate, and seeking prompt medical attention for new symptoms are essential steps to protect heart health. With modern surgical and transcatheter options, most patients with severe disease can look forward to a marked improvement in quality of life and survival.

References:

• Mayo Clinic. Aortic stenosis. https://www.mayoclinic.org/diseases-conditions/aortic-stenosis
• American Heart Association. 2024 AHA/ACC Valve Guidelines. https://www.ahajournals.org/valve-guidelines
• National Institutes of Health. Calcific Aortic Valve Disease. https://www.ncbi.nlm.nih.gov/books/NBK430805/
• Cleveland Clinic. Transcatheter Aortic Valve Replacement (TAVR). https://my.clevelandclinic.org/health/treatments/21516-transcatheter-aortic-valve-replacement
• World Health Organization. Cardiovascular disease prevention. https://www.who.int/health-topics/cardiovascular-diseases

```